GGrantIndex
← Leaderboards

Patrick G Sullivan

University Of Kentucky

$10,466,531
Attributed
$13,566,322
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,979,411 · 12
VA$0 · 1

By mechanism

P20$10,402,188 · 3
R01$7,743,771 · 4
P30$1,278,105 · 2
R21$365,277 · 1
R41$183,070 · 1
R13$7,000 · 1

Top collaborators

Most similar at University Of Kentucky

Same institution · by research overlap

Others in their field

Top investigators on “Synapses

Research focus

SynapsesNeuronsTissuesMitochondriaHomeostasisBioenergeticsBrain InjuriesTraumatic Brain InjuryDesignResponseDoseInjuryMitochondrial DysfunctionReactive Oxygen SpeciesLinkNeuropathologyBrainProductionPublishingTherapeutic TargetDosageUnited StatesBaseAdult

Grant awards (52)

Center of Biomedical Research Excellence in CNS Metabolism$2,122,307
P20 · FY2025 · GM · contact PI
CNS-Met Administrative Core$1,040,235
P20 · FY2025 · GM · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$683,169
R01 · FY2025 · NS · contact PI
CNS-Met Metabolomics Core$293,035
P20 · FY2025 · GM · contact PI
Targeting mitostasis via activation of mitochondrial biogenesis after TBI$0
I01 · FY2025 · VA · contact PI
Center of Biomedical Research Excellence in CNS Metabolism$2,130,945
P20 · FY2024 · GM · contact PI
CNS-Met Administrative Core$936,807
P20 · FY2024 · GM · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$691,959
R01 · FY2024 · NS · contact PI
CNS-Met Metabolomics Core$385,385
P20 · FY2024 · GM · contact PI
Targeting mitostasis via activation of mitochondrial biogenesis after TBI$0
I01 · FY2024 · VA · contact PI
Center of Biomedical Research Excellence in CNS Metabolism$2,159,837
P20 · FY2023 · GM · contact PI
CNS-Met Administrative Core$933,133
P20 · FY2023 · GM · contact PI
CNS-Met Metabolomics Core$400,504
P20 · FY2023 · GM · contact PI
Targeting mitostasis via activation of mitochondrial biogenesis after TBI$0
I01 · FY2023 · VA · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$612,006
R01 · FY2022 · NS · contact PI
Targeting mitostasis via activation of mitochondrial biogenesis after TBI$0
I01 · FY2022 · VA · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$620,851
R01 · FY2021 · NS · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$642,323
R01 · FY2020 · NS · contact PI
mitoNEET as a therapeutic target for TBI$0
I01 · FY2020 · VA · contact PI
mitoNEET as a therapeutic target for TBI$0
I01 · FY2019 · VA · contact PI
mitoNEET as a therapeutic target for TBI$0
I01 · FY2018 · VA · contact PI
mitoNEET as a therapeutic target for TBI$0
I01 · FY2017 · VA · contact PI
MICROSCOPY CORE$91,247
P30 · FY2015 · NS · contact PI
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$321,596
R01 · FY2014 · NS · contact PI
Mitochondrial Uncoupling as a Therapeutic Target in Obesity$183,070
R41 · FY2014 · DK · contact PI
MICROSCOPY CORE$96,986
P30 · FY2014 · NS · contact PI
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$313,474
R01 · FY2013 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$307,205
R01 · FY2013 · NS
MICROSCOPY CORE$91,084
P30 · FY2013 · NS · contact PI
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$74,177
R01 · FY2013 · NS · contact PI
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$324,844
R01 · FY2012 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$318,347
R01 · FY2012 · NS
MICROSCOPY CORE$94,051
P30 · FY2012 · NS · contact PI
Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury$324,844
R01 · FY2011 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$318,347
R01 · FY2011 · NS
MICROSCOPY CORE$114,602
P30 · FY2011 · NS · contact PI
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$321,596
R01 · FY2010 · NS
Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury$324,844
R01 · FY2009 · NS
Core--Microscopy, Image Analysis and Stereology$85,291
P30 · FY2009 · NS · contact PI
Mitochondrial Uncoupling as a Therapeutic Target in TBI$287,643
R01 · FY2008 · NS · contact PI
Core--Microscopy, Image Analysis and Stereology$82,809
P30 · FY2008 · NS · contact PI
14th Annual KSCHIRT Symposium, 2008$7,000
R13 · FY2008 · NS · contact PI
Mitochondrial Uncoupling as a Therapeutic Target in TBI$287,892
R01 · FY2007 · NS · contact PI
Core--Microscopy, Image Analysis and Stereology$230,783
P30 · FY2007 · NS · contact PI
Mitochondrial Uncoupling as a Therapeutic Target in TBI$296,757
R01 · FY2006 · NS · contact PI
Core--Microscopy, Image Analysis and Stereology$268,889
P30 · FY2006 · NS · contact PI
Mitochondrial Uncoupling as a Therapeutic Target in TBI$63,510
R01 · FY2006 · NS · contact PI
Mitochondrial Uncoupling as a Therapeutic Target in TBI$304,195
R01 · FY2005 · NS
Oxidative Stress and the Ketogenic Diet$176,678
R21 · FY2005 · NS
Core--Microscopy, Image Analysis and Stereology$122,363
P30 · FY2005 · NS
Mitochondrial Uncoupling as a Therapeutic Target in TBI$304,192
R01 · FY2004 · NS
Oxidative Stress and the Ketogenic Diet$188,599
R21 · FY2004 · NS